Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)
NCT00423280
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DRUG:
6R-BH4
Sponsor
University of Oxford
Collaborators
[object Object]